Is the Neutrophil-to-Lymphocyte Ratio an Exceptional Indicator for Metabolic Syndrome Disease and Outcomes?
- 23 November 2021
- journal article
- review article
- Published by Elsevier BV in Endocrine Practice
- Vol. 28 (3), 342-348
- https://doi.org/10.1016/j.eprac.2021.11.083
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Association of Neutrophil-Lymphocyte Ratio with Glucose Intolerance: An Indicator of Systemic Inflammation in Patients with Type 2 DiabetesDiabetes Technology & Therapeutics, 2014
- Benefits of the Neutrophil-to-Lymphocyte Ratio for the Prediction of Gestational Diabetes Mellitus in Pregnant WomenExperimental and Clinical Endocrinology & Diabetes, 2014
- Correlation of Neutrophil to Lymphocyte Ratio With the Presence and Severity of Metabolic SyndromeClinical and Applied Thrombosis/hemostasis, 2012
- The long-term predictive value of the neutrophil-to-lymphocyte ratio in Type 2 diabetic patients presenting with acute myocardial infarctionQJM: An International Journal of Medicine, 2012
- Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian populationInternational Archives of Medicine, 2012
- The Relationship Between Neutrophil-to-Lymphocyte Ratio and Inflammation in End-Stage Renal Disease PatientsRenal Failure, 2011
- Inflammation and metabolic disordersCurrent Opinion in Clinical Nutrition and Metabolic Care, 2008
- Inflammation and metabolic disordersNature, 2006
- Inflammation and Insulin ResistanceDiabetes Care, 2003
- The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndromeJournal of Diabetes and its Complications, 1997